An additional study has reported that Sivelestat reduces the content of pleural effusion as well as levels of albumin (a marker of lung permeability), decreases myeloperoxidase activity (indicating neutrophil infiltration), amplifies oxygenation, and improves the survival rate. This evidence concerns the gene ALB and Pleural effusion.